应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02235 微泰医疗-B
已收盘 11-10 15:37:37
6.700
-0.090
-1.33%
最高
6.790
最低
6.700
成交量
1.86万
今开
6.790
昨收
6.790
日振幅
1.33%
总市值
27.81亿
流通市值
10.99亿
总股本
4.15亿
成交额
12.62万
换手率
0.01%
流通股本
1.64亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
微泰医疗-B11月9日回购15,200股,涉资约10.11万港元
公告速递 · 11-09 17:45
微泰医疗-B11月9日回购15,200股,涉资约10.11万港元
微泰医疗-B(02235)11月9日斥资10.11万港元回购1.52万股
智通财经 · 11-09 17:45
微泰医疗-B(02235)11月9日斥资10.11万港元回购1.52万股
微泰医疗-B:H股全流通获联交所授出上市批准
新浪港股 · 11-09 07:32
微泰医疗-B:H股全流通获联交所授出上市批准
微泰医疗-B(02235.HK):H股全流通获联交所授出上市批准
智通财经 · 11-06
微泰医疗-B(02235.HK):H股全流通获联交所授出上市批准
微泰医疗-B获准250,087,968股未上市股份转换H股并上市
公告速递 · 11-06
微泰医疗-B获准250,087,968股未上市股份转换H股并上市
微泰医疗-B回购26,600股,耗资约17.59万港元
公告速递 · 11-06
微泰医疗-B回购26,600股,耗资约17.59万港元
微泰医疗-B(02235)11月6日耗资约17.59万港元回购2.66万股
智通财经 · 11-06
微泰医疗-B(02235)11月6日耗资约17.59万港元回购2.66万股
【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现
金吾财讯 · 11-06
【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现
微泰医疗-B更新10月股份变动月报表,股本保持稳定
公告速递 · 11-05
微泰医疗-B更新10月股份变动月报表,股本保持稳定
微泰医疗-B于11月5日回购12,500股,涉资约8.30万港元
公告速递 · 11-05
微泰医疗-B于11月5日回购12,500股,涉资约8.30万港元
微泰医疗-B(02235)11月5日耗资约8.3万港元回购1.25万股
智通财经 · 11-05
微泰医疗-B(02235)11月5日耗资约8.3万港元回购1.25万股
微泰医疗-B:11月4日回购2.16万股,耗资约14.42万港元
公告速递 · 11-04
微泰医疗-B:11月4日回购2.16万股,耗资约14.42万港元
微泰医疗-B(02235.HK)11月4日耗资约14.42万港元回购2.16万股
智通财经 · 11-04
微泰医疗-B(02235.HK)11月4日耗资约14.42万港元回购2.16万股
微泰医疗-B于11月3日回购1.09万股,涉资约7.30万港元
公告速递 · 11-03
微泰医疗-B于11月3日回购1.09万股,涉资约7.30万港元
微泰医疗-B(02235)11月3日斥资7.3万港元回购1.09万股
智通财经网 · 11-03
微泰医疗-B(02235)11月3日斥资7.3万港元回购1.09万股
微泰医疗-B(02235)发布董事会战略委员会工作细则 明确职责与运作机制
公告速递 · 11-02
微泰医疗-B(02235)发布董事会战略委员会工作细则 明确职责与运作机制
微泰医疗-B(02235)发布董事会提名委员会工作细则 进一步完善公司治理架构
公告速递 · 11-02
微泰医疗-B(02235)发布董事会提名委员会工作细则 进一步完善公司治理架构
微泰医疗-B(02235)公布董事会薪酬与考核委员会工作细则
公告速递 · 11-02
微泰医疗-B(02235)公布董事会薪酬与考核委员会工作细则
微泰医疗-B(02235)公布董事会审计委员会工作细则 明确职权及运作规则
公告速递 · 11-02
微泰医疗-B(02235)公布董事会审计委员会工作细则 明确职权及运作规则
微泰医疗-B(02235.HK)建议选举郑攀为执行董事
智通财经 · 11-02
微泰医疗-B(02235.HK)建议选举郑攀为执行董事
暂无数据
公司概况
公司名称:
微泰医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
微泰医疗器械(杭州)股份有限公司是一家主要从事医疗器械的研发、生产和销售的中国公司。该公司的主营业务是生产和销售血糖监测系统(BGMS)、持续葡萄糖监测系统(CGMS)和胰岛素泵系统。该公司在糖尿病监测、治疗、管理领域拥有产品组合,涵盖贴敷式胰岛素泵系统、持续葡萄糖监测系统、闭环人工胰腺系统、血糖监测系统以及糖尿病数字管理软件等产品。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02235","market":"HK","secType":"STK","nameCN":"微泰医疗-B","latestPrice":6.7,"timestamp":1794296257018,"preClose":6.79,"halted":0,"volume":18600,"delay":0,"changeRate":-0.013254786450662718,"floatShares":164000000,"shares":415000000,"eps":0.097161,"marketStatus":"已收盘","change":-0.09,"latestTime":"11-10 15:37:37","open":6.79,"high":6.79,"low":6.7,"amount":126160,"amplitude":0.013255,"askPrice":6.79,"askSize":12000,"bidPrice":6.625,"bidSize":800,"shortable":0,"etf":0,"ttmEps":0.229,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794360600000},"marketStatusCode":5,"adr":0,"listingDate":1634572800000,"exchange":"SEHK","adjPreClose":6.79,"openAndCloseTimeList":[[1794274200000,1794283200000],[1794286800000,1794297600000]],"volumeRatio":0.052118,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02235/tweets","defaultTab":"tweets","newsList":[{"id":"1179539286","title":"微泰医疗-B11月9日回购15,200股,涉资约10.11万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179539286","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179539286?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:45","pubTimestamp":1794217551,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司于2026年11月9日发布翌日披露报表,公告当日通过香港联交所场内交易回购15,200股股份,约占当日现有已发行股本的0.0093%。据披露,每股回购价格介乎6.6港元至6.7港元,合计付出101,113.50港元。公司于2026年6月10日获股东大会授权回购最多16,416,184股,至今已累计回购832,400股,占授权通过时已发行股本约0.5084%。公司同时声明已遵守香港联交所相关上市规则及适用法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B11月9日回购15,200股,涉资约10.11万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682980657","title":"微泰医疗-B(02235)11月9日斥资10.11万港元回购1.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2682980657","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682980657?lang=zh_cn&edition=full","pubTime":"2026-11-09 17:45","pubTimestamp":1794217526,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微泰医疗-B(02235)发布公告,于2026年11月9日斥资10.11万港元回购1.52万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682217648","title":"微泰医疗-B:H股全流通获联交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682217648","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682217648?lang=zh_cn&edition=full","pubTime":"2026-11-09 07:32","pubTimestamp":1794180720,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端微泰医疗-B(02235)发布公告,公司已于2026年11月5日获联交所批准,准许2.5亿股H股上市及买卖,惟须待转换及上市的所有其他条件获达成后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-11-09/doc-iniyauwa6430912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","IPOS","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681285016","title":"微泰医疗-B(02235.HK):H股全流通获联交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2681285016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681285016?lang=zh_cn&edition=full","pubTime":"2026-11-06 19:07","pubTimestamp":1793963245,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188344716","title":"微泰医疗-B获准250,087,968股未上市股份转换H股并上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1188344716","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188344716?lang=zh_cn&edition=full","pubTime":"2026-11-06 19:05","pubTimestamp":1793963132,"startTime":"0","endTime":"0","summary":"2026年11月6日,微泰医疗器械(杭州)股份有限公司发布公告称,公司已于2026年11月5日收到香港联合交易所有限公司对其实施H股全流通的上市批准。根据批准,合共250,087,968股未上市股份将转换为H股并在联交所上市交易,待完成相关转换及上市的其他条件后生效。公告显示,截至公告日,公司已发行股份总数为421,078,000股,其中H股169,175,842股,占总股本40.1768%;未上市股份251,902,158股,占总股本59.8232%。总股本保持不变,仍为421,078,000股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113180384","title":"微泰医疗-B回购26,600股,耗资约17.59万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113180384","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113180384?lang=zh_cn&edition=full","pubTime":"2026-11-06 18:31","pubTimestamp":1793961093,"startTime":"0","endTime":"0","summary":"2026年11月6日,微泰医疗器械(杭州)股份有限公司于香港联交所披露翌日披露报表,宣布当日场内回购26,600股股份,占回购前已发行股本约0.0163%。本次回购每股价格介乎6.555港元至6.645港元,总金额约17.59万港元。回购完成后,公司已发行股份数量降至162,927,842股,库存股份增至6,248,000股,合计仍为169,175,842股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B回购26,600股,耗资约17.59万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681852089","title":"微泰医疗-B(02235)11月6日耗资约17.59万港元回购2.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681852089","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681852089?lang=zh_cn&edition=full","pubTime":"2026-11-06 18:30","pubTimestamp":1793961056,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微泰医疗-B(02235)公布,2026年11月6日耗资约17.59万港元回购2.66万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681884015","title":"【券商聚焦】中信建投医疗器械和服务2027年投资策略:板块性机会逐渐显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2681884015","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681884015?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:57","pubTimestamp":1793926643,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指,Q3多家公司业绩超预期、27年有望业绩改善,板块效应将逐步体现。重点关注2027年业绩增长及持续改善的公司,未来有望实现业绩估值双击。预计多个高值耗材和IVD板块的集采及降价政策影响将于年底或明年初逐步出清,板块性投资机会逐步凸显。医疗器械板块具有全球竞争力的改进式创新、突破式创新的产品正在被逐步认可,也有一批公司积极战略拓展第二增长曲线、实现海外业务高增长,估值迎来上涨。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995353","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1502","01066","BK1189","02190","01302","BK1587","BK1615","PTH","BK1222","BK1501","LGHT","BK1593","IEIH","BK1571","RSPH","06826","BK1589","KCE","BK1247","BK1583","09996","BK1574","BK1515","159883","GDOC","MEDX","BK1591","BK1161","MDEV","BK1600","BK1617","00853","BK1584","BK1610","HK0000165453.HKD","LNGR","BK0276","00241","AGNG","02252","BK1100","BK1142","HART","LU0173614495.USD","02235","LU0287142896.SGD","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118023898","title":"微泰医疗-B更新10月股份变动月报表,股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1118023898","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118023898?lang=zh_cn&edition=full","pubTime":"2026-11-05 18:26","pubTimestamp":1793874387,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司于2026年11月5日披露截至2026年10月31日的股份变动月报表,报告期为2026年10月1日至10月31日。公告显示,公司注册股本为人民币421,078,000元,维持不变。公司本月各类股份注册股本分别为:H股169,175,842股,内资股212,162,222股,非上市外资股39,739,936股。报告期内,公司确认其H股继续符合最低15.4%的公众持股量要求。截至2026年10月底,公司已发行股份总数保持在169,175,842股,注册股本未发生变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199584309","title":"微泰医疗-B于11月5日回购12,500股,涉资约8.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199584309","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199584309?lang=zh_cn&edition=full","pubTime":"2026-11-05 18:16","pubTimestamp":1793873782,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司于2026年11月5日发布翌日披露报表,披露股份回购事项。公告显示,公司于2026年11月5日于香港联合交易所场内回购普通股12,500股,占回购前公司已发行股份的约0.0077%。本次回购每股价格介乎6.61港元至6.65港元,合计耗资约8.30万港元。回购完成后,公司已发行股份总数仍为169,175,842股,其中流通股数降至162,954,442股,库藏股增至6,221,400股。公司同时确认,此次交易严格遵守了香港联合交易所证券上市规则及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微泰医疗-B于11月5日回购12,500股,涉资约8.30万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681102867","title":"微泰医疗-B(02235)11月5日耗资约8.3万港元回购1.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681102867","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681102867?lang=zh_cn&edition=full","pubTime":"2026-11-05 18:15","pubTimestamp":1793873714,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微泰医疗-B(02235)公布,2026年11月5日耗资约8.3万港元回购1.25万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1519138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193578740","title":"微泰医疗-B:11月4日回购2.16万股,耗资约14.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193578740","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193578740?lang=zh_cn&edition=full","pubTime":"2026-11-04 18:06","pubTimestamp":1793786787,"startTime":"0","endTime":"0","summary":"微泰医疗-B于2026年11月4日发布公告称,当日于香港联交所场内回购普通股21,600股,占回购前已发行股本约0.0133%。每股回购价介乎港币6.645元至6.7元,总涉资约港币14.42万元。公告显示,公司于2026年6月10日通过回购授权,授权可回购股份总数为16,416,184股,截至目前共回购778,100股,占授权通过当日已发行股本约0.4752%。公司方面确认,本次回购符合香港联交所证券上市规则以及相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"微泰医疗-B:11月4日回购2.16万股,耗资约14.42万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680031216","title":"微泰医疗-B(02235.HK)11月4日耗资约14.42万港元回购2.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680031216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680031216?lang=zh_cn&edition=full","pubTime":"2026-11-04 18:02","pubTimestamp":1793786558,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166260252","title":"微泰医疗-B于11月3日回购1.09万股,涉资约7.30万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166260252","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166260252?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:43","pubTimestamp":1793699008,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司于2026年11月3日发布翌日披露报表,公告当日于香港联交所场内回购股份的具体情况。公告显示,当日公司回购普通股H股10,900股,约占已发行股本的0.0067%,每股回购价介乎6.69港元至6.70港元,累计涉资约7.30万港元。本次公告由执行董事及联席公司秘书施永辉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"微泰医疗-B于11月3日回购1.09万股,涉资约7.30万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680767749","title":"微泰医疗-B(02235)11月3日斥资7.3万港元回购1.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680767749","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680767749?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:38","pubTimestamp":1793698684,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微泰医疗-B(02235)发布公告,该公司于2026年11月3日斥资7.3万港元回购1.09万股股份,每股回购价格为6.69-6.7港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1100","02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117625609","title":"微泰医疗-B(02235)发布董事会战略委员会工作细则 明确职责与运作机制","url":"https://stock-news.laohu8.com/highlight/detail?id=1117625609","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117625609?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:51","pubTimestamp":1793631105,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司近日公布《董事会战略委员会工作细则》,对战略委员会的组成、职权、议事规则及工作程序等作出明确规定。公司为适应战略发展需要、增强核心竞争力、健全投资决策程序并提高决策质量,在董事会下专门设立战略委员会。战略委员会由3至7名董事组成。主席由董事长担任,任期与董事会任期一致,期满可连任。检查董事会或股东大会批准事项的实施情况;","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151810572","title":"微泰医疗-B(02235)发布董事会提名委员会工作细则 进一步完善公司治理架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1151810572","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151810572?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:51","pubTimestamp":1793631100,"startTime":"0","endTime":"0","summary":"2024年6月XX日,微泰医疗器械(杭州)股份有限公司公布《董事会提名委员会工作细则》。公司通过设立并明确提名委员会的组成、职责及运作机制,强化董事会治理结构,确保符合法律法规及《香港联合交易所有限公司证券上市规则》的相关要求。市场人士关注,此举有助于微泰医疗-B在董事会层面进一步强化合规与多元化建设,为公司持续发展奠定稳固的治理基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111347558","title":"微泰医疗-B(02235)公布董事会薪酬与考核委员会工作细则","url":"https://stock-news.laohu8.com/highlight/detail?id=1111347558","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111347558?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:45","pubTimestamp":1793630728,"startTime":"0","endTime":"0","summary":"微泰医疗器械(杭州)股份有限公司近日发布《董事会薪酬与考核委员会工作细则》,明确委员会的组成、职权及运作规则等关键事项。主席由独立非执行董事选举产生,委员会任期与董事会任期一致。向董事会建议执行董事、非执行董事及独立非执行董事薪酬;审批高级管理层薪酬建议。微泰医疗-B表示,通过完善薪酬与考核委员会的制度建设,有助于进一步规范董事及高管薪酬管理,提升公司治理水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192575459","title":"微泰医疗-B(02235)公布董事会审计委员会工作细则 明确职权及运作规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1192575459","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192575459?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:41","pubTimestamp":1793630473,"startTime":"0","endTime":"0","summary":"2024年X月XX日,微泰医疗器械(杭州)股份有限公司在港交所网站披露《董事会审计委员会工作细则》,就审计委员会的组成、职权范围、议事规则及信息披露等作出具体规定,主要要点如下:。审计委员会由非执行董事组成,成员不少于三名,且独立非执行董事须占半数以上;上述《董事会审计委员会工作细则》自董事会审议通过之日起生效,如与相关法律法规或《香港上市规则》出现不一致,以后者为准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680768002","title":"微泰医疗-B(02235.HK)建议选举郑攀为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2680768002","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680768002?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:03","pubTimestamp":1793628213,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02235","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0286},{"period":"3month","weight":-0.0699},{"period":"6month","weight":-0.1339},{"period":"1year","weight":-0.0059},{"period":"ytd","weight":-0.1438}],"compareEarnings":[{"period":"1week","weight":0.0451},{"period":"1month","weight":0.0098},{"period":"3month","weight":-0.0469},{"period":"6month","weight":-0.0735},{"period":"1year","weight":-0.0683},{"period":"ytd","weight":-0.0461}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微泰医疗器械(杭州)股份有限公司是一家主要从事医疗器械的研发、生产和销售的中国公司。该公司的主营业务是生产和销售血糖监测系统(BGMS)、持续葡萄糖监测系统(CGMS)和胰岛素泵系统。该公司在糖尿病监测、治疗、管理领域拥有产品组合,涵盖贴敷式胰岛素泵系统、持续葡萄糖监测系统、闭环人工胰腺系统、血糖监测系统以及糖尿病数字管理软件等产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.189861},{"month":2,"riseRate":0.4,"avgChangeRate":-0.078129},{"month":3,"riseRate":0.4,"avgChangeRate":0.009968},{"month":4,"riseRate":0.4,"avgChangeRate":-0.003701},{"month":5,"riseRate":0,"avgChangeRate":-0.088227},{"month":6,"riseRate":0.2,"avgChangeRate":-0.027697},{"month":7,"riseRate":0.2,"avgChangeRate":0.007766},{"month":8,"riseRate":0.6,"avgChangeRate":0.002033},{"month":9,"riseRate":0.2,"avgChangeRate":-0.028452},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063695},{"month":11,"riseRate":0.833333,"avgChangeRate":0.031312},{"month":12,"riseRate":0.8,"avgChangeRate":0.248824}],"exchange":"SEHK","name":"微泰医疗-B","nameEN":"MICROTECH MED-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微泰医疗-B(02235)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微泰医疗-B(02235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微泰医疗-B,02235,微泰医疗-B股票,微泰医疗-B股票老虎,微泰医疗-B股票老虎国际,微泰医疗-B行情,微泰医疗-B股票行情,微泰医疗-B股价,微泰医疗-B股市,微泰医疗-B股票价格,微泰医疗-B股票交易,微泰医疗-B股票购买,微泰医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微泰医疗-B(02235)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微泰医疗-B(02235)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}